10-Q: Cyanotech Reports Mixed Results for Second Quarter and First Half of Fiscal 2025 Amidst Inventory and Demand Shifts

Sentiment:

Quarterly Report


Cyanotech Corporation reported a decrease in second-quarter sales and gross profit, while experiencing a slight increase in sales for the first six months of fiscal year 2025, as the company navigates inventory restocking and demand fluctuations.

Worse than expectedThe company's second-quarter net sales decreased by 8.3% year-over-year, indicating worse than expected performance.The company's gross profit margin decreased to 25.3% in the second quarter, down from 32.8% in the prior year, indicating worse than expected profitability.The company's operating loss increased to $975,000 in the second quarter, compared to $632,000 in the prior year, indicating worse than expected operational performance.The company's net loss increased to $1.150 million in the second quarter, compared to $797,000 in the prior year, indicating worse than expected overall financial performance.

Summary

  • Cyanotech Corporation, a microalgae-based nutrition company, announced its financial results for the second quarter and first six months of fiscal year 2025, ending September 30, 2024.
  • Second-quarter net sales decreased by 8.3% to $5.845 million, compared to $6.373 million in the same period last year.
  • The company's gross profit for the second quarter was $1.479 million, with a gross profit margin of 25.3%, down from $2.088 million and 32.8% respectively, in the prior year.
  • The operating loss for the second quarter was $975,000, compared to an operating loss of $632,000 in the same period of the previous year.
  • Net loss for the second quarter was $1.150 million, or $0.16 per diluted share, compared to a net loss of $797,000, or $0.13 per diluted share, in the prior year.
  • For the first six months of fiscal year 2025, net sales increased by 1.9% to $11.743 million, compared to $11.519 million in the same period last year.
  • Gross profit for the first six months was $2.956 million, with a gross profit margin of 25.2%, down from $3.620 million and 31.4% respectively, in the prior year.
  • The operating loss for the first six months was $2.016 million, compared to an operating loss of $1.841 million in the same period of the previous year.
  • Net loss for the first six months was $2.352 million, or $0.34 per diluted share, compared to a net loss of $2.166 million, or $0.34 per diluted share, in the prior year.
  • The company experienced a 39% increase in bulk sales and a 156% increase in contract extraction revenue in the second quarter, but a 21% decrease in packaged goods sales due to stock shortages and timing issues.

Sentiment

Score: 4

Explanation: The document presents a mixed picture with some positive developments in bulk sales and contract extraction, but overall, the financial results are worse than the previous year, with decreased sales, gross profit margins, and increased losses. The company also faces challenges with inventory and debt covenants, which raises concerns about its financial stability.

Positives

  • The company saw a 1.9% increase in net sales for the first six months of fiscal year 2025.
  • Bulk sales increased by 39% in the second quarter, indicating strong demand in this segment.
  • Contract extraction revenue grew significantly by 156% in the second quarter.
  • The company is actively working to replenish packaged goods stock and promote its products.

Negatives

  • Second-quarter net sales decreased by 8.3% compared to the same period last year.
  • Gross profit margin decreased in both the second quarter and the first six months of fiscal year 2025.
  • Operating losses increased in both the second quarter and the first six months of fiscal year 2025.
  • Packaged goods sales decreased by 21% in the second quarter due to stock shortages and timing issues.
  • The company experienced a net loss of $1.150 million in the second quarter and $2.352 million in the first six months of fiscal year 2025.

Risks

  • The company's financial performance is subject to fluctuations in sales volumes to its largest customers.
  • Weather patterns in Hawaii can impact production levels.
  • Increased competition in the market could affect pricing and sales.
  • The company faces risks associated with new products and foreign exchange fluctuations.
  • Availability of financing and national and global economic conditions can impact the company's performance.
  • The company's debt service coverage ratio and current ratio fell short of the bank's annual requirements as of March 31, 2024, although a waiver was obtained.
  • The company's ability to continue as a going concern is dependent on achieving its operating plan and cash flow projections.

Future Outlook

The company will focus on stabilizing production volume, rationalizing market channel participation, and leveraging core competencies, with an emphasis on Nutrex Hawaiian consumer products and exploring bulk sales opportunities. The company also expects to generate additional income from extraction services. Gross profit margins may be impacted by lower production volumes, input costs, and competition. The company will balance production with sales demand and manage expenses judiciously. The company's future results are subject to various risks and uncertainties.

Management Comments

  • In prior quarters, our inventory levels were reduced to just-in-time levels to manage cash flow and strong sales in the first quarter of fiscal 2025 decreased inventory.
  • However, mid-quarter financing allowed us to start restocking, increasing work-in-progress inventory by $1.9 million, even though finished goods were still down by $1.5 million.
  • Bulk inventory, which has a shorter production time, helped drive a 39% increase in sales, and revenue from contract extraction grew by 156%.
  • However, packaged goods, which take longer to restock, saw a 21% decrease due to stock shortages and timing issues, contributing to an overall 8% drop in total sales for the quarter.
  • While progress with packaged goods has been slower than expected, we're working quickly to replenish stock and continue promoting our algae-based products farmed in Hawaii's pristine waters.

Industry Context

The company operates in the natural products industry, specifically in the production of microalgae-based dietary supplements. The industry is subject to various factors, including consumer demand for natural products, competition, and regulatory changes. The company's performance is also influenced by weather patterns and production challenges specific to microalgae cultivation.

Comparison to Industry Standards

  • Cyanotech's gross profit margin of 25.3% for the second quarter and 25.2% for the first six months of fiscal 2025 is lower than the previous year, indicating potential challenges in cost management or pricing strategies compared to industry benchmarks.
  • The company's operating losses of $975,000 for the second quarter and $2.016 million for the first six months of fiscal 2025 suggest that the company is facing challenges in controlling operating expenses compared to industry standards.
  • The company's reliance on a few major customers for a significant portion of its revenue and accounts receivable poses a concentration risk, which is a common concern in the industry.
  • The company's debt levels and covenant violations indicate potential financial instability, which is a concern compared to industry peers with stronger balance sheets.
  • The company's focus on bulk sales and contract extraction services, in addition to packaged goods, is a strategy that some companies in the industry use to diversify revenue streams.

Related Party Transactions

  • The company has a loan facility with a related party that allows it to borrow up to $4.0 million on a revolving basis.
  • As of September 30, 2024, the company had $2.0 million outstanding borrowings on the Revolver, which was included in line of credit related party on the Condensed Consolidated Balance Sheets.
  • The company also has a $1,000,000 loan outstanding with the same related party.

Stakeholder Impact

  • Shareholders may be concerned about the decreased sales, gross profit margins, and increased losses.
  • Employees may be affected by the company's cost-saving initiatives, including reduced headcount and compensation.
  • Customers may experience stock shortages and timing issues with packaged goods.
  • Suppliers may be impacted by the company's efforts to manage inventory and production levels.
  • Creditors may be concerned about the company's debt levels and covenant violations.

Next Steps

  • The company will continue to focus on replenishing packaged goods stock.
  • The company will continue to promote its algae-based products.
  • The company will continue to explore opportunities for bulk sales orders.
  • The company will continue to generate income from extraction services.
  • The company will continue to strive for continuous improvements in processes and production methods to stabilize costs and production levels.

Key Dates

DateDescription
March 3, 1983Cyanotech Corporation was incorporated in the state of Nevada.
August 14, 2012Date of the original Term Loan Agreement with a lender for $5,500,000.
June 3, 2016Cyanotech entered into a Credit Agreement with First Foundation Bank.
April 2019Cyanotech obtained a $1,500,000 loan from Skywords Family Foundation.
April 12, 2021The Skywords Note was amended, converting $500,000 into a revolving loan and extending the expiration.
December 14, 2022The Skywords Note was further amended, increasing the revolving amount to $1,000,000.
June 22, 2023First Foundation Bank issued a letter waiving a debt covenant violation as of March 31, 2023.
August 14, 2023The Skywords Note was further amended, increasing the revolving amount to $2,000,000.
October 13, 2023First Foundation Bank converted the Line of Credit to a term loan of $1,480,000.
March 6, 2024Michael Davis, Chairman of the Board, entered into a trading plan.
August 9, 2024The Skywords Note was further amended, increasing the revolving amount to $4,000,000 and extending the maturity.
August 28, 2024First Foundation Bank extended the maturity date of the 2023 Loan to March 31, 2025.
September 10, 202466,667 shares of fully vested restricted stock were issued to a board member.
September 12, 2024First Foundation Bank issued a letter waiving debt covenant violations as of March 31, 2024.
September 30, 2024End of the reporting period for the quarterly report.
October 1, 2024Michael Davis's trading plan completed the purchase of 315,000 shares and was terminated.
October 1, 202413,158 shares of fully vested restricted stock were issued to a board member.
November 12, 2024Date of the release of the quarterly report.
November 13, 2024Cyanotech will host a virtual broadcast to respond to questions about its operating results.

Keywords

Cyanotech, microalgae, astaxanthin, spirulina, dietary supplements, financial results, net sales, gross profit, operating loss, net loss, bulk sales, packaged goods, contract extraction, inventory, Hawaii

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.